William J Sandborn Selected Research

William J Sandborn Research Topics

Disease

247	Crohn Disease (Crohn's Disease) 04/2024 - 01/2002
223	Ulcerative Colitis 04/2024 - 04/2002
112	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2024 - 01/2002
49	Infections 12/2023 - 12/2002
31	Necrosis 01/2023 - 02/2003
31	Inflammation (Inflammations) 01/2023 - 05/2002
28	Hemorrhage 04/2024 - 12/2005
28	Neoplasms (Cancer) 02/2024 - 04/2002
15	Colitis 03/2023 - 04/2002
15	Body Weight (Weight, Body) 10/2022 - 11/2004
13	Fistula 01/2019 - 09/2002
10	Ulcer 10/2023 - 04/2012
10	Rheumatoid Arthritis 01/2022 - 05/2002
9	Abdominal Pain (Pain, Abdominal) 04/2024 - 08/2013
9	Pouchitis 01/2022 - 04/2002
8	Tuberculosis (Tuberculoses) 12/2023 - 12/2002
8	Herpes Zoster 04/2023 - 10/2009
8	Skin Neoplasms (Skin Cancer) 04/2023 - 04/2014
8	Diarrhea 12/2019 - 11/2002
7	Pathologic Constriction (Stenosis) 10/2023 - 05/2004
7	Obesity 01/2021 - 01/2017
7	Colorectal Neoplasms (Colorectal Cancer) 05/2017 - 01/2006
7	Delayed Hypersensitivity (Hypersensitivity, Type IV) 05/2010 - 05/2002
6	Opportunistic Infections (Opportunistic Infection) 04/2023 - 04/2008
6	Proctitis 11/2022 - 05/2012
6	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 05/2015
6	Lymphoma (Lymphomas) 01/2022 - 01/2002
5	Headache (Headaches) 01/2023 - 08/2003
5	Sepsis (Septicemia) 08/2022 - 04/2009
5	Abscess 01/2019 - 01/2009
5	Disease Progression 01/2016 - 02/2006
4	Pulmonary Embolism 04/2023 - 01/2018
4	Melanoma (Melanoma, Malignant) 04/2023 - 01/2019
4	Venous Thrombosis (Deep-Vein Thrombosis) 04/2023 - 11/2019
4	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 03/2023 - 06/2003
4	Arthralgia (Joint Pain) 01/2023 - 02/2006
4	Injection Site Reaction 01/2022 - 02/2006
4	Hypersensitivity (Allergy) 01/2019 - 10/2004
4	Multiple Sclerosis 01/2018 - 01/2004
4	Leukopenia 01/2018 - 07/2003
4	Weight Loss (Weight Reduction) 01/2018 - 11/2002

Drug/Important Bio-Agent (IBA)

75	Infliximab (Remicade)FDA Link 12/2021 - 05/2002
61	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 05/2002
53	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024 - 08/2002
51	vedolizumabIBA 04/2024 - 01/2004
44	Monoclonal AntibodiesIBA 12/2023 - 05/2002
42	Adalimumab (Humira)FDA Link 11/2022 - 02/2003
34	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 01/2004
31	C-Reactive ProteinIBA 01/2024 - 12/2003
31	Mesalamine (Mesalazine)FDA LinkGeneric 01/2022 - 01/2002
28	Ustekinumab (CNTO 1275)FDA Link 02/2024 - 10/2008
28	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2003
27	tofacitinibIBA 04/2023 - 08/2012
25	Certolizumab Pegol FDA Link 01/2022 - 02/2003
24	Azathioprine (Imuran)FDA LinkGeneric 07/2022 - 01/2002
22	Immunosuppressive Agents (Immunosuppressants)IBA 12/2023 - 12/2003
19	IntegrinsIBA 04/2024 - 11/2003
19	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2024 - 11/2008
17	Janus Kinase InhibitorsIBA 04/2023 - 08/2012
17	SteroidsIBA 01/2020 - 09/2002
17	Budesonide (Pulmicort)FDA LinkGeneric 12/2017 - 01/2002
15	golimumab FDA Link 01/2023 - 01/2014
15	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2022 - 01/2002
14	Immunologic Factors (Immunomodulators)IBA 04/2024 - 12/2008
13	AntibodiesIBA 11/2021 - 02/2003
12	Interleukin-12 (IL 12)IBA 10/2022 - 05/2002
10	CytokinesIBA 01/2022 - 05/2002
10	Interleukin-23 (Interleukin 23)IBA 01/2022 - 10/2008
8	Phenobarbital (Luminal)FDA Link 10/2023 - 05/2006
8	Natalizumab (Tysabri)FDA Link 01/2018 - 05/2002
7	InterleukinsIBA 01/2023 - 03/2015
7	ozanimodIBA 01/2022 - 01/2016
6	ontamalimabIBA 12/2023 - 01/2017
6	Serum AlbuminIBA 10/2022 - 04/2012
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2007
6	risankizumabIBA 01/2022 - 01/2017
6	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 12/2002
5	Prostaglandins AIBA 01/2024 - 01/2016
5	etrolizumabIBA 01/2023 - 07/2014
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2002
5	AlbuminsIBA 01/2021 - 01/2013
5	LactoferrinIBA 01/2020 - 06/2003
5	Sulfasalazine (Azulfidine)FDA LinkGeneric 04/2010 - 01/2002
4	omega-Chloroacetophenone (Mace)IBA 02/2024 - 01/2019
4	etrasimodIBA 01/2024 - 01/2020
4	Sphingosine-1-Phosphate ReceptorsIBA 01/2024 - 01/2020
4	guselkumabIBA 12/2023 - 01/2022
4	Janus KinasesIBA 04/2023 - 09/2014
4	mirikizumabIBA 01/2023 - 01/2020
4	Opiate AlkaloidsIBA 01/2023 - 01/2021
4	Janus Kinase 1IBA 01/2022 - 01/2020
4	upadacitinibIBA 01/2022 - 01/2020
4	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 08/2006

Therapy/Procedure

222	Therapeutics 04/2024 - 01/2002
31	Biological Therapy 01/2023 - 05/2002
17	Colectomy 10/2021 - 04/2002
15	Remission Induction 01/2020 - 01/2002
9	Restorative Proctocolectomy 01/2022 - 09/2002
6	Aftercare (After-Treatment) 01/2022 - 10/2009
5	Drug Therapy (Chemotherapy) 01/2020 - 12/2005